Clinical Excellence

Clinical
Excellence

Our Commitment to
Clinical Excellence

We are dedicated to clinical excellence, from the quality of our testing, to offering resources, education, and the reporting of real-time drug use trends. Our Clinical Affairs team is passionate about providing everything needed for clinicians to get the most of their patients’ test results, and includes:

A credentialed field clinical team of PharmDs, PhDs and a nurse clinical resource specialist
Toxicologists available via our RADAR® Hotline
A team of PhD-level genetic scientists

Millennium Health in the News

Processing hundreds of thousands of specimens each year allows us to provide real-time analytics and positioned Millennium Health as a valuable resource for national and regional media covering important topics including the drug overdose crisis and emerging trends in illicit and prescription drug use in the U.S.

Our research has been featured in:

US News & World Report in 2019 and 2020
USA Today
Addiction Professional in 2019 and 2020
Practical Pain Management
Cincinnati Enquirer

Providing Timely Data
on Drug Use Trends

As part of our commitment to clinical excellence, we conduct ongoing evaluation of our drug test results (using Intellium℠) with the goal of providing timely information to help improve the efficient use of available resources and ultimately curb the significant impact of drug overdose deaths. Additionally, our analysis of pharmacogenetic test results continues to reveal important findings with regard to the impact and frequency of variation in drug response genes in the United States.

Millennium Health’s Ongoing
Commitment to Service,
Support and Clinical Education

Collaboration with the U.S. Department of
Health and Human Services

Processing hundreds of thousands of specimens each year allows us to provide real-time analytics regarding emerging drug use trends, such as our studies published in JAMA Network Open and the Millennium Health Signals Report™ and has resulted in our collaboration with the U.S. Department of Health and Human Services to help fight our nation’s drug overdose crisis.

Read Press Release

Published in JAMA Network Open

Evaluation of Trends of Near-Real-Time Urine Drug Test Results for Methamphetamine, Cocaine, Heroin, and Fentanyl

Twillman RK, Dawson E, LaRue L et al. Evaluation of Trends of Near Real-Time Urine Drug Test Results for Cocaine, Methamphetamine, Heroin and Fentanyl. JAMA Netw Open. 2020;3(1):e1918514. doi:10.1001/jamanetworkopen.2019.18514

READ MORE →

Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine

LaRue L, Twillman RK, Dawson E., et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open.2019;2(4):e192851. Doi:10.1001/jamanetworkopen.2019.2851

READ MORE →

View Other Publications →

Millennium Health Signals Report™

Our annual Millennium Health Signals Report identifies national and regional drug use trends through analyzing our proprietary database of urine drug test results.

Millennium Health’s Signals Report™ COVID-19 Special Edition Reveals Significant Changes in Drug Use During the Pandemic

Millennium Health conducted an analysis of over 500,000 definitive urine drug test (UDT) results for non-prescribed fentanyl, cocaine, heroin, and methamphetamine in the periods before and after COVID-19 was declared a national emergency.

READ MORE →

Millennium Health Signals Report™ – Volume 2 (2020) Identifies a Significant Increase in Urine Drug Test Positivity for Fentanyl, Methamphetamine, and Kratom

We analyzed our proprietary database of urine drug test results from January 2015 through November 2019 to identify national and regional trends in positivity rates of select drugs of abuse and emerging threats.

READ MORE →

Education Resources and
Programs for Clinicians

Millennium Health is dedicated to supporting patient care by providing resources and education. We have a variety of educational pieces and technical bulletins designed to help you interpret test results and support clinical decision-making.

Our education programs cover a myriad of topics relevant to your practice and patient population, including the clinical value of urine drug testing and pharmacogenetic testing in the management of pain, mental health, and substance use disorders, risk management when prescribing controlled substances, and current trends in the use of natural and synthetic drugs of abuse. Programs can be scheduled with your local Sales Representative to be delivered virtually or live by a member of our field Clinical Affairs team.